➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Dow
Harvard Business School
Express Scripts
Moodys

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Patent: 8,071,556

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,071,556
Title:Peptide substance revealing a stress protective effect, pharmaceutical composition on its base, and the method of its application
Abstract: Disclosed is a peptide glutamyl-aspartyl-glycine with general formula H-Glu-Asp-Gly-OH sequence 1 [SEQ ID NO:1], having a stress protective effect. Also disclosed is a pharmaceutical composition comprising the peptide and a pharmaceutically acceptable carrier. Also disclosed is a method of preventing or treating functional or stress induced disorders in a patient wherein the method involves administering an effective amount of the peptide to the patient.
Inventor(s): Khavinson; Vladimir Khatskelevich (St. Petersburg, RU), Grigoriev; Evgeny Iosifovich (St. Petersburg, RU), Malinin; Vladimir Victorovich (St. Petersburg, RU), Ryzhak; Galina Anatolievna (St. Petersburg, RU)
Assignee: Obschestvo S Ogranichennoi Otvetstevennostyu \"Sia Peptides\" (Saint-Petersburg, RU)
Application Number:12/298,430
Patent Claims:see list of patent claims

Details for Patent 8,071,556

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial Obschestvo S Ogranichennoi Otvetstevennostyu \"Sia Peptides\" (Saint-Petersburg, RU) 2026-05-23 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial Obschestvo S Ogranichennoi Otvetstevennostyu \"Sia Peptides\" (Saint-Petersburg, RU) 2026-05-23 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
McKesson
Moodys
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.